Sotalol Hydrochloride

盐酸索他洛尔

Report date: 2023/04/21 17:24:44
NME

Base Information

Drug NameSotalol Hydrochloride
Drug Alias Name梭达罗盐酸甲磺胺心定盐酸心得怡索它洛尔索地洛尔 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersBeta adrenergic receptors antagonists
TargetsPotassium channelBeta adrenergic receptors
Therapy Area/IndicationsMyocardial InfarctionTachycardia, SupraventricularAtrial Flutter +[6] 
Global Approved IndicationsMyocardial InfarctionTachycardia, SupraventricularAtrial Flutter +[6] 
Approved Indications in ChinaMyocardial InfarctionTachycardia, SupraventricularAtrial Flutter +[5] 
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCovis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesCovis PharmaLegacy Pharma IncSandoz Ltd +[5] 
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionTachycardia, SupraventricularAtrial Flutter +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeC07AA07
Related LinksWikipediaDrugBankKEGG